The FDA approved Moderna's mFlusiva in August, and it's now available to adults 50 and older.

Learn how personalized cancer vaccines work and what to watch for at ESMO 2026. A vaccine made from a person’s own tumor has become the first of its kind to succeed in a phase 3 trial. Full results ...

Top US experts on Timesnownews.com - From geopolitics to AI to lifestyle, get the views from the best in the world.

For some older adults, the flu vaccine could look a little different this year. In August, the US Food and Drug Administration approved the nation’s first mRNA-based flu vaccine for use in people 50 ...

Queen Mary University of London scientists found that adding the Nodamura virus B2 protein to self-amplifying mRNA vaccines ...

Skepticism about the government’s pandemic response is one thing. Writing off mRNA vaccine technology is another.

The first mRNA flu shot is now available, but not everyone is eligible. Moderna’s mFlusiva is the first flu vaccine in the United States to use messenger RNA technology, the same platform used in ...

Now is around the time when flu season usually starts to pick up — except this year, cases have been rising since late summer ...

The U.S. FDA has approved Moderna’s mFlusiva, the first seasonal flu vaccine using mRNA technology, for adults 50 and older. Examining the importance of this development and the science behind, in an ...

The FDA has approved mFlusiva, the first mRNA flu vaccine, for adults ages 50 to 64, but the CDC has not added it to its recommended list amid legal uncertainties and disruptions to the federal ...

Stephen Hoge and Dean Li, at the STAT Summit, spoke of how Merck and Moderna will pair Keytruda with personalized mRNA ...

One of the beneficial characteristics of the response to the COVID -19 pandemic were pledges from companies involved in developing vaccines (such as Moderna, Pfizer, BioNTech, and others) not to ...